NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA
NCT03353753 2022-11-21INVICTUSDeciphera Pharmaceuticals, LLCPhase 3 Completed129 enrolled 19 charts 2 FDA
NCT02508532 2022-06-21(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid TumorsBlueprint Medicines CorporationPhase 1 Completed250 enrolled 36 charts 2 FDA